$OMER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OMEROS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OMEROS CORP. Get notifications about new insider transactions in OMEROS CORP for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Option Exercise | M | 4.10 | 35,206 | 144,345 | 147,426 | |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Option Exercise | M | 4.10 | 37,407 | 153,369 | 182,632 | |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Sell | S | 17.76 | 35,206 | 625,259 | 2,026,986 | 2.1 M to 2 M (-1.71 %) |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Buy | M | 4.10 | 35,206 | 144,345 | 2,062,192 | 2 M to 2.1 M (+1.74 %) |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Sell | S | 17.91 | 37,407 | 669,959 | 2,026,986 | 2.1 M to 2 M (-1.81 %) |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Buy | M | 4.10 | 37,407 | 153,369 | 2,064,393 | 2 M to 2.1 M (+1.85 %) |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Option Exercise | M | 10.27 | 8,100 | 83,187 | 65,000 | |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Option Exercise | M | 10.27 | 10,000 | 102,700 | 73,100 | |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Sell | S | 23.28 | 8,100 | 188,568 | 14,000 | 22.1 K to 14 K (-36.65 %) |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Buy | M | 10.27 | 8,100 | 83,187 | 22,100 | 14 K to 22.1 K (+57.86 %) |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Sell | S | 22.64 | 10,000 | 226,400 | 14,000 | 24 K to 14 K (-41.67 %) |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Buy | M | 10.27 | 10,000 | 102,700 | 24,000 | 14 K to 24 K (+71.43 %) |
| Jan 21 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Option Exercise | M | 9.37 | 10,000 | 93,700 | 19,188 | |
| Jan 21 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Buy | M | 9.37 | 10,000 | 93,700 | 14,000 | 4 K to 14 K (+250.00 %) |
| Jan 21 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Sell | S | 19.95 | 9,500 | 189,525 | 4,000 | 13.5 K to 4 K (-70.37 %) |
| Jan 15 2021 | OMER | OMEROS CORP | Cable Thomas J. | Option Exercise | M | 4.53 | 5,000 | 22,650 | 0 | ||
| Jan 15 2021 | OMER | OMEROS CORP | Cable Thomas J. | Sell | S | 16.97 | 5,000 | 84,850 | 35,067 | 40.1 K to 35.1 K (-12.48 %) | |
| Jan 15 2021 | OMER | OMEROS CORP | Cable Thomas J. | Buy | M | 4.53 | 5,000 | 22,650 | 40,067 | 35.1 K to 40.1 K (+14.26 %) | |
| Oct 28 2020 | OMER | OMEROS CORP | Cancelmo Peter B | VP, GEN. COUNSEL & ... | Option Exercise | A | 10.22 | 20,000 | 204,400 | 20,000 | |
| Oct 28 2020 | OMER | OMEROS CORP | Cancelmo Peter B | VP, GEN. COUNSEL & ... | Option Exercise | A | 10.22 | 20,000 | 204,400 | 20,000 | |
| Jun 09 2020 | OMER | OMEROS CORP | Cable Thomas J. | Option Exercise | A | 14.66 | 7,500 | 109,950 | 7,500 | ||
| Jun 09 2020 | OMER | OMEROS CORP | Demopulos Peter A MD | Option Exercise | A | 14.66 | 7,500 | 109,950 | 7,500 | ||
| Jun 09 2020 | OMER | OMEROS CORP | Hood Leroy E. MD PhD | Option Exercise | A | 14.66 | 7,500 | 109,950 | 7,500 | ||
| Jun 09 2020 | OMER | OMEROS CORP | Aspiri Ray | Option Exercise | A | 14.66 | 7,500 | 109,950 | 7,500 | ||
| Jun 09 2020 | OMER | OMEROS CORP | Shah Rajiv | Option Exercise | A | 14.66 | 7,500 | 109,950 | 7,500 | ||
| Jun 09 2020 | OMER | OMEROS CORP | Bumol Thomas F. | Option Exercise | A | 14.66 | 7,500 | 109,950 | 7,500 | ||
| Jun 09 2020 | OMER | OMEROS CORP | HANISH ARNOLD C | Option Exercise | A | 14.66 | 7,500 | 109,950 | 7,500 | ||
| May 15 2020 | OMER | OMEROS CORP | Cable Thomas J. | Option Exercise | M | 5.92 | 5,000 | 29,600 | 0 | ||
| May 15 2020 | OMER | OMEROS CORP | Cable Thomas J. | Sell | S | 14.40 | 5,000 | 71,999 | 35,067 | 40.1 K to 35.1 K (-12.48 %) | |
| May 15 2020 | OMER | OMEROS CORP | Cable Thomas J. | Buy | M | 5.92 | 5,000 | 29,600 | 40,067 | 35.1 K to 40.1 K (+14.26 %) | |
| Mar 17 2020 | OMER | OMEROS CORP | Hood Leroy E. MD PhD | Option Exercise | M | 5.92 | 5,000 | 29,600 | 0 | ||
| Mar 17 2020 | OMER | OMEROS CORP | Hood Leroy E. MD PhD | Buy | M | 5.92 | 5,000 | 29,600 | 69,390 | 64.4 K to 69.4 K (+7.77 %) | |
| Mar 03 2020 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHIARMAN, CEO & PRE ... | Option Exercise | A | 11.91 | 450,000 | 5,359,500 | 450,000 | |
| Mar 03 2020 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Option Exercise | A | 11.91 | 70,000 | 833,700 | 70,000 | |
| Mar 03 2020 | OMER | OMEROS CORP | Cancelmo Peter B | VP, GEN. COUNSEL & ... | Option Exercise | A | 11.91 | 50,000 | 595,500 | 50,000 | |
| Feb 12 2020 | OMER | OMEROS CORP | Zumwalt Kurt | Director | Option Exercise | A | 12.73 | 11,750 | 149,578 | 11,750 | |
| Feb 12 2020 | OMER | OMEROS CORP | Zumwalt Kurt | Director | Option Exercise | A | 12.73 | 15,000 | 190,950 | 15,000 | |
| Dec 17 2019 | OMER | OMEROS CORP | Hood Leroy E. MD PhD | Director | Option Exercise | M | 7.56 | 10,000 | 75,600 | 0 | |
| Dec 17 2019 | OMER | OMEROS CORP | Hood Leroy E. MD PhD | Director | Buy | M | 7.56 | 10,000 | 75,600 | 64,390 | 54.4 K to 64.4 K (+18.39 %) |
| Dec 17 2019 | OMER | OMEROS CORP | Demopulos Peter A MD | Director | Option Exercise | M | 7.56 | 3,334 | 25,205 | 0 | |
| Dec 17 2019 | OMER | OMEROS CORP | Demopulos Peter A MD | Director | Buy | M | 7.56 | 3,334 | 25,205 | 188,516 | 185.2 K to 188.5 K (+1.80 %) |
| Dec 05 2019 | OMER | OMEROS CORP | Cable Thomas J. | Director | Option Exercise | M | 7.56 | 10,000 | 75,600 | 0 | |
| Dec 05 2019 | OMER | OMEROS CORP | Cable Thomas J. | Director | Sell | S | 14.41 | 10,000 | 144,148 | 35,067 | 45.1 K to 35.1 K (-22.19 %) |
| Dec 05 2019 | OMER | OMEROS CORP | Cable Thomas J. | Director | Buy | M | 7.56 | 10,000 | 75,600 | 45,067 | 35.1 K to 45.1 K (+28.52 %) |
| Oct 16 2019 | OMER | OMEROS CORP | Cable Thomas J. | Director | Sell | S | 15.12 | 5,000 | 75,590 | 35,067 | 40.1 K to 35.1 K (-12.48 %) |
| Jun 11 2019 | OMER | OMEROS CORP | Cancelmo Peter B | See Remarks | Option Exercise | A | 16.63 | 20,000 | 332,600 | 20,000 | |
| Jun 11 2019 | OMER | OMEROS CORP | Shah Rajiv | Director | Option Exercise | A | 16.87 | 7,500 | 126,525 | 7,500 | |
| Jun 11 2019 | OMER | OMEROS CORP | Hood Leroy E. MD PhD | Director | Option Exercise | A | 16.87 | 7,500 | 126,525 | 7,500 | |
| Jun 11 2019 | OMER | OMEROS CORP | HANISH ARNOLD C | Director | Option Exercise | A | 16.87 | 7,500 | 126,525 | 7,500 | |
| Jun 11 2019 | OMER | OMEROS CORP | Demopulos Peter A MD | Director | Option Exercise | A | 16.87 | 7,500 | 126,525 | 7,500 | |
| Jun 11 2019 | OMER | OMEROS CORP | Cable Thomas J. | Director | Option Exercise | A | 16.87 | 7,500 | 126,525 | 7,500 | |
| Jun 11 2019 | OMER | OMEROS CORP | Aspiri Ray | Director | Option Exercise | A | 16.87 | 7,500 | 126,525 | 7,500 | |
| Jun 11 2019 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 6.05 | 10,000 | 60,500 | 43,996 | |
| Jun 11 2019 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 6.05 | 10,000 | 60,500 | 210,645 | 200.6 K to 210.6 K (+4.98 %) |
| Feb 12 2019 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | A | 13.45 | 65,000 | 874,250 | 65,000 | |
| Feb 12 2019 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | A | 13.45 | 65,000 | 874,250 | 65,000 | |
| Feb 12 2019 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Option Exercise | A | 13.45 | 425,000 | 5,716,250 | 425,000 | |
| Feb 12 2019 | OMER | OMEROS CORP | Bumol Thomas F. | Director | Option Exercise | A | 13.45 | 15,000 | 201,750 | 15,000 | |
| Aug 31 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 6.05 | 8,000 | 48,400 | 53,996 | |
| Aug 31 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 4.10 | 7,529 | 30,869 | 0 | |
| Aug 31 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 4.10 | 35,000 | 143,500 | 7,529 | |
| Aug 31 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 6.05 | 8,000 | 48,400 | 200,645 | 192.6 K to 200.6 K (+4.15 %) |
| Aug 31 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Sell | S | 25.93 | 5,337 | 138,376 | 192,645 | 198 K to 192.6 K (-2.70 %) |
| Aug 31 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Sell | S | 25.31 | 2,192 | 55,469 | 197,982 | 200.2 K to 198 K (-1.10 %) |
| Aug 31 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 4.10 | 7,529 | 30,869 | 200,174 | 192.6 K to 200.2 K (+3.91 %) |
| Aug 31 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Sell | S | 24.45 | 35,000 | 855,750 | 192,645 | 227.6 K to 192.6 K (-15.37 %) |
| Aug 31 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 4.10 | 35,000 | 143,500 | 227,645 | 192.6 K to 227.6 K (+18.17 %) |
| Jul 30 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 4.10 | 5,723 | 23,464 | 42,529 | |
| Jul 30 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 6.05 | 8,000 | 48,400 | 61,996 | |
| Jul 30 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 4.10 | 35,000 | 143,500 | 48,252 | |
| Jul 30 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Sell | S | 21.73 | 5,723 | 124,357 | 192,645 | 198.4 K to 192.6 K (-2.89 %) |
| Jul 30 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 4.10 | 5,723 | 23,464 | 198,368 | 192.6 K to 198.4 K (+2.97 %) |
| Jul 30 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 6.05 | 8,000 | 48,400 | 192,645 | 184.6 K to 192.6 K (+4.33 %) |
| Jul 30 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Sell | S | 21.53 | 35,000 | 753,687 | 184,645 | 219.6 K to 184.6 K (-15.93 %) |
| Jul 30 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 4.10 | 35,000 | 143,500 | 219,645 | 184.6 K to 219.6 K (+18.96 %) |
| Jul 13 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 4.10 | 4,277 | 17,536 | 83,252 | |
| Jul 13 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Sell | S | 21.48 | 4,277 | 91,886 | 184,645 | 188.9 K to 184.6 K (-2.26 %) |
| Jul 13 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 4.10 | 4,277 | 17,536 | 188,922 | 184.6 K to 188.9 K (+2.32 %) |
| Jul 13 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 4.10 | 4,277 | 17,536 | 83,252 | |
| Jul 13 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Sell | S | 21.48 | 4,277 | 91,886 | 184,645 | 188.9 K to 184.6 K (-2.26 %) |
| Jul 13 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 4.10 | 4,277 | 17,536 | 188,922 | 184.6 K to 188.9 K (+2.32 %) |
| Jun 18 2018 | OMER | OMEROS CORP | Shah Rajiv | Director | Option Exercise | A | 19.91 | 7,500 | 149,325 | 7,500 | |
| Jun 18 2018 | OMER | OMEROS CORP | HANISH ARNOLD C | Director | Option Exercise | A | 19.91 | 7,500 | 149,325 | 7,500 | |
| Jun 18 2018 | OMER | OMEROS CORP | Hood Leroy E. MD PhD | Director | Option Exercise | A | 19.91 | 7,500 | 149,325 | 7,500 | |
| Jun 18 2018 | OMER | OMEROS CORP | Demopulos Peter A MD | Director | Option Exercise | A | 19.91 | 7,500 | 149,325 | 7,500 | |
| Jun 18 2018 | OMER | OMEROS CORP | Cable Thomas J. | Director | Option Exercise | A | 19.91 | 7,500 | 149,325 | 7,500 | |
| Jun 18 2018 | OMER | OMEROS CORP | Aspiri Ray | Director | Option Exercise | A | 19.91 | 7,500 | 149,325 | 7,500 | |
| May 16 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | M | 9.37 | 5,000 | 46,850 | 29,188 | |
| May 16 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | M | 9.37 | 12,812 | 120,048 | 34,188 | |
| May 16 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | M | 9.37 | 10,980 | 102,883 | 47,000 | |
| May 16 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Buy | M | 9.37 | 5,000 | 46,850 | 13,500 | 8.5 K to 13.5 K (+58.82 %) |
| May 16 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Sell | S | 24.95 | 12,812 | 319,659 | 8,500 | 21.3 K to 8.5 K (-60.12 %) |
| May 16 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Buy | M | 9.37 | 12,812 | 120,048 | 21,312 | 8.5 K to 21.3 K (+150.73 %) |
| May 16 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Sell | S | 22.45 | 10,980 | 246,501 | 8,500 | 19.5 K to 8.5 K (-56.37 %) |
| May 16 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Buy | M | 9.37 | 10,980 | 102,883 | 19,480 | 8.5 K to 19.5 K (+129.18 %) |
| Apr 11 2018 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Option Exercise | A | 13.58 | 350,000 | 4,753,000 | 350,000 | |
| Apr 10 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | A | 13.58 | 60,000 | 814,800 | 60,000 | |
| Apr 10 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | A | 13.58 | 65,000 | 882,700 | 65,000 | |
| Apr 10 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | A | 13.58 | 60,000 | 814,800 | 60,000 | |
| Apr 10 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | A | 13.58 | 65,000 | 882,700 | 65,000 | |
| Jan 05 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 6.05 | 5,004 | 30,274 | 69,996 | |
| Jan 05 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 6.05 | 3,000 | 18,150 | 0 | |
| Jan 05 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 9.37 | 62,528 | 585,887 | 40,972 | |
| Jan 05 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 6.05 | 5,004 | 30,274 | 184,645 | 179.6 K to 184.6 K (+2.79 %) |
| Jan 05 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 6.05 | 3,000 | 18,150 | 179,641 | 176.6 K to 179.6 K (+1.70 %) |
| Jan 05 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Sell | S | 21.45 | 62,528 | 1,341,226 | 176,641 | 239.2 K to 176.6 K (-26.14 %) |
| Jan 05 2018 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 9.37 | 62,528 | 585,887 | 239,169 | 176.6 K to 239.2 K (+35.40 %) |
| Jan 05 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | M | 9.37 | 1,000 | 9,370 | 57,980 | |
| Jan 05 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | M | 9.37 | 1,020 | 9,557 | 58,980 | |
| Jan 05 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Buy | M | 9.37 | 1,000 | 9,370 | 8,500 | 7.5 K to 8.5 K (+13.33 %) |
| Jan 05 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Sell | S | 22.45 | 1,020 | 22,899 | 7,500 | 8.5 K to 7.5 K (-11.97 %) |
| Jan 05 2018 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Buy | M | 9.37 | 1,020 | 9,557 | 8,520 | 7.5 K to 8.5 K (+13.60 %) |
| Dec 28 2017 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Option Exercise | M | 4.10 | 39,961 | 163,840 | 220,039 | |
| Dec 28 2017 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Option Exercise | M | 2.45 | 102,040 | 249,998 | 0 | |
| Dec 28 2017 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Buy | M | 4.10 | 39,961 | 163,840 | 2,026,986 | 2 M to 2 M (+2.01 %) |
| Dec 28 2017 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Buy | M | 2.45 | 102,040 | 249,998 | 1,987,025 | 1.9 M to 2 M (+5.41 %) |
| Aug 21 2017 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 6.05 | 8,000 | 48,400 | 3,000 | |
| Aug 21 2017 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 6.05 | 8,000 | 48,400 | 176,641 | 168.6 K to 176.6 K (+4.74 %) |
| Jun 16 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | M | 9.37 | 14,000 | 131,180 | 60,000 | |
| Jun 16 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Sell | S | 24.95 | 12,000 | 299,400 | 7,500 | 19.5 K to 7.5 K (-61.54 %) |
| Jun 16 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Buy | M | 9.37 | 14,000 | 131,180 | 19,500 | 5.5 K to 19.5 K (+254.55 %) |
| Jun 16 2017 | OMER | OMEROS CORP | Hood Leroy E. MD PhD | Director | Option Exercise | A | 23.75 | 10,000 | 237,500 | 10,000 | |
| Jun 16 2017 | OMER | OMEROS CORP | Demopulos Peter A MD | Director | Option Exercise | A | 23.75 | 10,000 | 237,500 | 10,000 | |
| Jun 16 2017 | OMER | OMEROS CORP | Cable Thomas J. | Director | Option Exercise | A | 23.75 | 10,000 | 237,500 | 10,000 | |
| Jun 16 2017 | OMER | OMEROS CORP | Shah Rajiv | Director | Option Exercise | A | 23.75 | 10,000 | 237,500 | 10,000 | |
| Jun 16 2017 | OMER | OMEROS CORP | Aspiri Ray | Director | Option Exercise | A | 23.75 | 10,000 | 237,500 | 10,000 | |
| Jun 16 2017 | OMER | OMEROS CORP | HANISH ARNOLD C | Director | Option Exercise | A | 23.75 | 10,000 | 237,500 | 10,000 | |
| Jun 15 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | M | 9.37 | 14,000 | 131,180 | 74,000 | |
| Jun 15 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | M | 9.37 | 12,850 | 120,405 | 88,000 | |
| Jun 15 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | M | 9.37 | 2,650 | 24,831 | 100,850 | |
| Jun 15 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Sell | S | 22.45 | 12,000 | 269,400 | 5,500 | 17.5 K to 5.5 K (-68.57 %) |
| Jun 15 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Buy | M | 9.37 | 14,000 | 131,180 | 17,500 | 3.5 K to 17.5 K (+400.00 %) |
| Jun 15 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Sell | S | 19.95 | 9,350 | 186,533 | 3,500 | 12.9 K to 3.5 K (-72.76 %) |
| Jun 15 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Buy | M | 9.37 | 12,850 | 120,405 | 12,850 | 0 to 12.9 K |
| Jun 15 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Sell | S | 19.95 | 2,650 | 52,868 | 0 | 2.7 K to 0 (-100.00 %) |
| Jun 15 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Buy | M | 9.37 | 2,650 | 24,831 | 2,650 | 0 to 2.7 K |
| Apr 14 2017 | OMER | OMEROS CORP | Cable Thomas J. | Director | Sell | S | 16.49 | 3,000 | 49,474 | 40,067 | 43.1 K to 40.1 K (-6.97 %) |
| Mar 22 2017 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | M | 6.05 | 2,040 | 12,342 | 11,000 | |
| Mar 22 2017 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Buy | M | 6.05 | 2,040 | 12,342 | 168,641 | 166.6 K to 168.6 K (+1.22 %) |
| Feb 28 2017 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Option Exercise | A | 11.55 | 375,000 | 4,331,250 | 375,000 | |
| Feb 28 2017 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | A | 11.55 | 75,000 | 866,250 | 75,000 | |
| Feb 28 2017 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | A | 11.55 | 70,000 | 808,500 | 70,000 | |
| Dec 16 2016 | OMER | OMEROS CORP | Cable Thomas J. | Director | Sell | S | 10.21 | 3,000 | 30,642 | 43,067 | 46.1 K to 43.1 K (-6.51 %) |
| Dec 07 2016 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP Finance and CAO | Option Exercise | A | 10.56 | 85,000 | 897,600 | 85,000 | |
| Dec 07 2016 | OMER | OMEROS CORP | Kelbon Marcia S. | VP Patent and Gener ... | Option Exercise | A | 10.56 | 80,000 | 844,800 | 80,000 | |
| Dec 07 2016 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Option Exercise | M | 0.98 | 102,044 | 100,003 | 0 | |
| Dec 07 2016 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Option Exercise | M | 0.98 | 102,040 | 99,999 | 102,044 | |
| Dec 07 2016 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Option Exercise | A | 10.56 | 400,000 | 4,224,000 | 400,000 | |
| Dec 07 2016 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Option Exercise | M | 0.98 | 102,040 | 99,999 | 204,084 | |
| Dec 07 2016 | OMER | OMEROS CORP | Demopulos Gregory A MD | Chairman, CEO & Pre ... | Sell | S | 10.48 | 102,044 | 1,069,033 | 1,884,985 | 2 M to 1.9 M (-5.14 %) |